Clinical Trial Update: Misoprostol as First Aid Measure to Address Excessive Postpartum Bleeding [Phase 4]

View source ↗

Summary

An update on a Phase 4 study evaluating misoprostol as a first-aid measure to address postpartum hemorrhage, with the trial status listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• Cytotec (misoprostol)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Postpartum Hemorrhage | Phase 4 | Status: UNKNOWN